Approval · Notice of Compliance 24909 · 2021
QVAR: Notice of Compliance 24909
Issued January 1, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24909
- Date
- January 1, 2021
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Updates to the packaging section in the product monograph. change in product ownership
Products in this notice
Medicinal ingredients
- BECLOMETHASONE DIPROPIONATE 50 MCG per ACT
- BECLOMETHASONE DIPROPIONATE 100 MCG per ACT